Profile data is unavailable for this security.
About the company
Japan Lifeline Co Ltd is a Japan-based company engaged in the manufacture, import, and sale of medical devices, mainly in the cardiovascular field. The Company's products include cardiac pacemakers, implantable cardioverter defibrillators (ICDs), and biventricular pacemakers with defibrillation function (CRT-Ds) used to treat cardiac arrhythmias, electrophysiology (EP) catheters used to examine cardiac arrhythmias, ablation catheters used to treat arrhythmias, artificial blood vessels, frozen elephant trunks, and stent grafts used to treat aortic diseases, embolization coils, thrombus aspiration catheters, and stent retrievers used in cerebrovascular treatment, as well as colonic stents, gastric and duodenal stents used to treat digestive diseases, radiofrequency ablation electrode needles for the treatment of liver cancer, and bile duct tube stents.
- Revenue in JPY (TTM)58.20bn
- Net income in JPY9.07bn
- Incorporated1981
- Employees1.25k
- LocationJapan Lifeline Co Ltd25F, NYK Tennoz Bldg.,2-2-20, Higashi-ShinagawaSHINAGAWA-KU 140-0002JapanJPN
- Phone+81 367115200
- Websitehttps://www.jll.co.jp
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nagaileben Co Ltd | 16.69bn | 2.48bn | 55.23bn | 501.00 | 22.29 | 1.42 | 20.04 | 3.31 | 80.62 | 80.62 | 544.00 | 1,263.59 | 0.3898 | 1.32 | 4.20 | 33,321,640.00 | 5.78 | 6.90 | 6.13 | 7.43 | 39.37 | 43.35 | 14.84 | 18.68 | 10.68 | -- | 0.00 | 67.12 | 3.48 | -0.097 | -8.81 | -5.82 | 16.97 | 0.00 |
| TAUNS Laboratories Inc | 14.92bn | 3.69bn | 55.44bn | 316.00 | 15.34 | 3.18 | 12.48 | 3.71 | 33.95 | 33.95 | 139.96 | 163.58 | 0.3721 | 0.9162 | 2.13 | 47,226,430.00 | 9.20 | -- | 13.12 | -- | 64.90 | -- | 24.72 | -- | 0.9488 | 31.13 | 0.56 | -- | 1.05 | -- | 9.38 | -- | -- | -- |
| Kitazato Corp | 10.98bn | 3.98bn | 62.08bn | 86.00 | 15.58 | 3.20 | 14.89 | 5.65 | 99.60 | 99.60 | 274.45 | 485.65 | 0.5723 | 1.83 | 8.92 | -- | 20.77 | -- | 21.73 | -- | 66.93 | -- | 36.29 | -- | 14.33 | -- | 0.00 | -- | 2.20 | -- | -4.63 | -- | -- | -- |
| Shofu Inc | 38.97bn | 4.25bn | 64.60bn | 1.41k | 15.17 | 1.41 | 11.92 | 1.66 | 118.98 | 118.98 | 1,092.32 | 1,279.85 | 0.7574 | 1.23 | 9.81 | 27,577,490.00 | 8.28 | 7.27 | 9.27 | 8.24 | 59.45 | 58.41 | 10.94 | 9.75 | 2.72 | -- | 0.00 | 32.99 | 10.31 | 8.19 | 18.11 | 43.72 | -3.19 | 30.39 |
| Eiken Chemical Co Ltd | 41.28bn | 3.83bn | 87.46bn | 702.00 | 21.82 | 1.91 | 13.75 | 2.12 | 116.07 | 116.07 | 1,238.23 | 1,326.89 | 0.6669 | 2.86 | 3.23 | 58,797,720.00 | 6.19 | 7.23 | 8.08 | 9.10 | 39.63 | 45.17 | 9.29 | 10.64 | 1.37 | 33.81 | 0.0642 | 40.76 | 1.22 | 2.07 | -15.41 | -8.83 | 13.89 | 12.05 |
| Japan Lifeline Co Ltd | 58.20bn | 9.07bn | 100.68bn | 1.25k | 10.92 | 1.57 | 9.35 | 1.73 | 129.28 | 129.28 | 829.90 | 900.80 | 0.7918 | 1.29 | 3.97 | 46,563,200.00 | 12.34 | 8.99 | 14.81 | 11.26 | 59.78 | 58.12 | 15.58 | 12.65 | 2.09 | -- | 0.0486 | 72.63 | 10.17 | 1.81 | 23.98 | 3.76 | -9.05 | 12.82 |
| PHC Holdings Corp | 363.93bn | 3.54bn | 130.78bn | 9.04k | 37.63 | 0.8196 | 4.34 | 0.3593 | 27.43 | 27.43 | 2,861.02 | 1,259.09 | 0.6623 | 3.40 | 5.24 | 40,253,730.00 | 0.6038 | 0.106 | 1.12 | 0.1617 | 45.25 | 46.91 | 0.9117 | 0.1738 | 0.3606 | 1.64 | 0.6084 | 916.51 | 2.17 | 5.81 | 181.32 | 14.73 | -1.83 | -- |
| Menicon Co Ltd | 123.91bn | 6.85bn | 139.71bn | 4.33k | 19.98 | 1.44 | 8.35 | 1.13 | 91.07 | 91.07 | 1,629.40 | 1,267.14 | 0.6123 | 2.52 | 8.55 | 28,650,640.00 | 3.39 | 4.12 | 4.19 | 5.14 | 53.67 | 53.02 | 5.54 | 5.61 | 1.86 | -- | 0.4421 | 29.35 | 4.56 | 7.53 | 23.87 | 6.72 | 21.98 | 14.87 |
| Hogy Medical Co Ltd | 37.84bn | 222.00m | 150.76bn | 1.41k | 647.27 | 1.94 | 26.62 | 3.98 | 10.34 | 10.34 | 1,754.86 | 3,454.27 | 0.3919 | 2.75 | 2.87 | 26,856,640.00 | 0.2299 | 3.51 | 0.2523 | 3.86 | 32.30 | 37.88 | 0.5867 | 9.38 | 4.14 | 60.78 | 0.1404 | 54.66 | 0.0972 | 1.00 | -45.79 | -22.76 | -12.15 | 3.92 |
Data as of Feb 17 2026. Currency figures normalised to Japan Lifeline Co Ltd's reporting currency: Japanese Yen JPY
20.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sompo Asset Management Co. Ltd.as of 14 Feb 2025 | 3.33m | 4.67% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 1.91m | 2.68% |
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 1.65m | 2.32% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 05 Feb 2026 | 1.53m | 2.14% |
| Ranmore Fund Management Ltd.as of 31 Oct 2025 | 1.50m | 2.10% |
| Ichiyoshi Asset Management Co., Ltd.as of 30 Jun 2025 | 1.35m | 1.90% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 1.02m | 1.43% |
| Amova Asset Management Co., Ltd.as of 06 Feb 2026 | 774.10k | 1.09% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 748.00k | 1.05% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 738.20k | 1.04% |
More ▼
Data from 20 Aug 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
